Literature DB >> 10349634

Segmental expression of aggrecan in the non-segmented perinotochordal sheath underlies normal segmentation of the vertebral column.

J Bundy1, R Rogers, S Hoffman, S J Conway.   

Abstract

The embryonic vertebral column is derived from the unsegmented axial mesenchyme surrounding the notochord, and its development and differentiation are influenced by the notochord. The role of cartilage in determining the ultimate pattern of the segmental skeleton has been well documented, but a gene whose segmental expression corresponds to the pattern of the developing skeleton has yet to be identified. We show that chick aggrecan is initially expressed within the entire length of the notochord, and as development proceeds, aggrecan expression becomes restricted to the surrounding perinotochordal sheath in a segmental pattern, mirroring the differentiated somite pattern.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10349634     DOI: 10.1016/s0925-4773(98)00179-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  4 in total

1.  Notochordal and foregut abnormalities correlate with elevated neural crest apoptosis in Patch embryos.

Authors:  Paige Snider; Olga Simmons; Rhonda Rogers; Rachel Young; Mica Gosnell; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-06

2.  Analyzing notochord segmentation and intervertebral disc formation using the twhh:gfp transgenic zebrafish model.

Authors:  Yutaka Haga; Vincent J Dominique; Shao Jun Du
Journal:  Transgenic Res       Date:  2009-04-04       Impact factor: 2.788

3.  Attractive and permissive activities of semaphorin 5A toward dorsal root ganglion axons in higher vertebrate embryos.

Authors:  Tomoyuki Masuda; Chie Sakuma; Hiroyuki Yaginuma; Masahiko Taniguchi
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

4.  A New Look at Etiological Factors of Idiopathic Scoliosis: Neural Crest Cells.

Authors:  Alla M Zaydman; Elena L Strokova; Elena V Kiseleva; Lubov A Suldina; Anton A Strunov; Alexander I Shevchenko; Pavel P Laktionov; Vladimir M Subbotin
Journal:  Int J Med Sci       Date:  2018-03-06       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.